Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer

[1]  A. Schally,et al.  Differential immunostaining of various types of breast carcinomas for growth hormone‐releasing hormone receptor – Apocrine epithelium and carcinomas emerging as uniformly positive , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  I. Holen,et al.  Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo , 2012, Breast Cancer Research.

[3]  Smita Misra,et al.  High Motility of Triple-negative Breast Cancer Cells Is Due to Repression of Plakoglobin Gene by Metastasis Modulator Protein SLUG* , 2012, The Journal of Biological Chemistry.

[4]  Z. Aktary,et al.  Plakoglobin: Role in Tumorigenesis and Metastasis , 2012, International journal of cell biology.

[5]  Shan Zhu,et al.  NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer , 2011, PloS one.

[6]  G. Morel,et al.  Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  Yibin Kang,et al.  Signaling pathways in breast cancer metastasis - novel insights from functional genomics , 2011, Breast Cancer Research.

[8]  G. O'Neill,et al.  Estradiol stabilizes the 105-kDa phospho-form of the adhesion docking protein NEDD9 and suppresses NEDD9-dependent cell spreading in breast cancer cells. , 2011, Biochimica et biophysica acta.

[9]  A. Klein-Szanto,et al.  Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9. , 2010, Cancer research.

[10]  K. Green,et al.  Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling , 2010, Journal of Cell Science.

[11]  M. Wolfson,et al.  NEDD9 promotes oncogenic signaling in mammary tumor development. , 2009, Cancer research.

[12]  R. Mansel,et al.  Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome , 2008, World journal of surgical oncology.

[13]  J. Massagué,et al.  Genetic determinants of cancer metastasis , 2007, Nature Reviews Genetics.

[14]  R. Kåresen,et al.  Expression pattern of adhesion molecules (E‐cadherin, α‐, β‐, γ‐catenin and claudin‐7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis , 2007 .

[15]  A. de Bruin,et al.  Pemphigus vulgaris identifies plakoglobin as key suppressor of c‐Myc in the skin , 2006, The EMBO journal.

[16]  K. Green,et al.  Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Gluckman,et al.  Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Oren,et al.  PML Is a Target Gene of β-Catenin and Plakoglobin, and Coactivates β-Catenin-mediated Transcription , 2002 .

[19]  L. Miller,et al.  A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron. , 2002, Cancer research.

[20]  L. Kindblom,et al.  Growth hormone receptor is expressed in human breast cancer. , 2001, The American journal of pathology.

[21]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[22]  P. Lobie,et al.  Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent. , 2000, Endocrinology.

[23]  A. Børresen-Dale,et al.  Re‐expression of E‐cadherin, α‐catenin and β‐catenin, but not of γ‐catenin, in metastatic tissue from breast cancer patients , 2000 .

[24]  H. Varmus,et al.  Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling. , 1999, Molecular biology of the cell.

[25]  H. Höfler,et al.  Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility , 1999, Oncogene.

[26]  A. Børresen-Dale,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .

[27]  M. Waters,et al.  Cellular expression of growth hormone and prolactin receptors in human breast disorders , 1998, International journal of cancer.

[28]  W. Birchmeier,et al.  Expression of E-cadherin/catenin complexes in breast cancer. , 1997, International journal of oncology.

[29]  E. Gelmann,et al.  Alterations in β-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells , 1994 .

[30]  A. Yap,et al.  Contact inhibition of cell spreading: a mechanism for the maintenance of thyroid cell aggregation in vitro. , 1993, Experimental cell research.

[31]  K. Pavelić,et al.  Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants. , 1986, Cancer research.

[32]  R. Kåresen,et al.  Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[33]  A. Hart,et al.  Molecular markers of breast cancer metastasis , 2005 .

[34]  M. Einarson,et al.  Dissection of HEF1-dependent functions in motility and transcriptional regulation. , 2002, Journal of cell science.

[35]  A. Børresen-Dale,et al.  Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. , 2000, The Journal of pathology.

[36]  A. Børresen-Dale,et al.  E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. , 1998, The Journal of pathology.

[37]  E. Gelmann,et al.  Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. , 1994, Cancer research.

[38]  Sujata Roy,et al.  Regulation of (cid:98) -Catenin Levels and Localization by Overexpression of Plakoglobin and Inhibition of the Ubiquitin-Proteasome System , 2022 .